Work

Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma

Year: 1999

Type: article

Study design: Clinical Trial

Source: Annals of Oncology

DOI: 10.1023/a:1008389119525

Authors: L.D. Piro, C.A. White, A.J. Grillo-López, N. Janakiraman, A. Saven, T.M. Beck, C. Varns, S. Shuey, M. Czuczman, J.W. Lynch, J.E. Kolit, V. Jain

Institutions: Cedars-Sinai Medical Center, University of California, Los Angeles, Henry Ford Hospital, St. Luke's Mountain States Tumor Institute, Scripps Clinic, Roswell Park Comprehensive Cancer Center, University of Florida, North Shore University Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2099314298

FWCI: 12.33

Cites: 16

Cited by: 370

Related to: 10